NEOPROBE CORP
S-3/A, EX-23.2, 2000-06-12
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: NEOPROBE CORP, S-3/A, EX-23.1, 2000-06-12
Next: HUNTINGTON FUNDS /MA/, 40-17F2, 2000-06-12



<PAGE>   1
                                                                    Exhibit 23.2



                       CONSENT OF INDEPENDENT ACCOUNTANTS

We consent to the incorporation by reference in this Registration Statement on
Form S-3 of our report dated February 20, 1998, on our audit of the consolidated
financial statements of Neoprobe Corporation and Subsidiaries for the year ended
December 31, 1997.


                                               /s/ PricewaterhouseCoopers LLP

                                               PricewaterhouseCoopers LLP

Columbus, Ohio

June 12, 2000

                                      II-7


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission